|
Volumn 140, Issue 4, 2000, Pages 541-551
|
The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patients
a a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
AGED;
ARTICLE;
ARTIFICIAL HEART PACEMAKER;
COST EFFECTIVENESS ANALYSIS;
FEMALE;
HEART ATRIUM FIBRILLATION;
HEART VENTRICLE PACING;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SICK SINUS SYNDROME;
SINUS NODE DYSFUNCTION;
STROKE;
SUPRAVENTRICULAR TACHYCARDIA;
UNITED STATES;
|
EID: 0033814363
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1067/mhj.2000.109652 Document Type: Article |
Times cited : (134)
|
References (31)
|